• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Cureus . Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients

tetano

Editor, Senior Moderator
Cureus


. 2021 Feb 7;13(2):e13210.
doi: 10.7759/cureus.13210.
Intensive Care Resources and 60-Day Survival of Critically-Ill COVID-19 Patients


Corinna N Lang[SUP] 1 2 [/SUP], Viviane Zotzmann[SUP] 1 2 [/SUP], Bonaventura Schmid[SUP] 3 [/SUP], Michael Berchtold-Herz[SUP] 4 [/SUP], Stefan Utzolino[SUP] 5 [/SUP], Paul Biever[SUP] 1 2 [/SUP], Daniel Duerschmied[SUP] 1 2 [/SUP], Christoph Bode[SUP] 1 2 [/SUP], Tobias Wengenmayer[SUP] 1 2 [/SUP], Dawid L Staudacher[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: Germany reported sufficient intensive care unit (ICU) resources throughout the first wave of coronavirus disease 2019 (COVID-19). The treatment of critically ill COVID-19 patients without rationing may improve the outcome. We therefore analyzed ICU resources allocated to COVID-19 patients with respiratory failure and their outcomes.
Methods: Retrospectively, we enrolled severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) polymerase chain reaction (PCR)-positive patients with respiratory failure from 03/08/2020 to 04/08/2020 and followed until 05/28/2020 in the university hospital of Freiburg, Germany.
Results: In the defined interval, 34 COVID-19 patients were admitted to the ICU with median age of 67?13 (31-86) years. Six of 34 (17.6%) were female. All patients suffered from moderate or severe acute respiratory distress syndrome (ARDS), 91.2% of the patients were intubated and 23.5% required extracorporeal membrane oxygenation (ECMO). Proning was performed in 67.6%, renal replacement therapy (RRT) was required in 35.3%. Ninety-six percent required more than 20 nursing hours per day. Mean ICU stay was 21?19 (1-81) days. Sixty-day survival of critically ill COVID-19 patients was 50.0% (17/34). Causes of death were multi-organ failure (52.9%), refractory ARDS (17.6%) and intracerebral hemorrhage (17.6%).
Conclusions: Treatment of critically ill COVID-19 patients is protracted and resource-intense. In a context without resources shortage, 50% of COVID-19 with respiratory failure survived up to 60 days.

Keywords: 60-day survival; ards; covid-19; icu resources.
 
Back
Top Bottom